Money is finally flowing into this undiscovered small-cap nuclear stock. The company has a history of explosive rallies in short periods of time. In December 2024, it surged from $2 to $24 in just a few weeks $FNUC
$CPSH is a micro-cap advanced materials play making metal-matrix composites for power electronics, defense, and energy — a quiet supply chain chokepoint that flew under the radar until FY2025 delivered record sales of $32.6M (+54% YoY). Q1 2026 was rough on the surface — revenue missed, gross margin compressed to 8.6%, stock sold off hard — but management flagged order timing as the culprit, not demand, and backed that up with a $4M hermetic packaging order booked right after quarter end. A facility expansion is underway to unlock production capacity, a new CFO with Precision Castparts pedigree just stepped in, and Citadel quietly initiated a position in Q1. At a ~$75M market cap with a $6 analyst target and 19% annual revenue growth forecast, this one’s worth watching as a defense/power electronics sleeper with a potential re-rate catalyst if Q2/Q3 execution follows through.
Not financial advice. DYOR.
Good evening from the Coconut Tree
@KamalaHarris
Ma’am, (can we call you Ma'am?) we’ll keep this factual and review your actual record, not your reboot.
As a U.S. Senator (2017-2021), you were an original cosponsor of the Green New Deal resolution (S.Res. 59).
It directed the US to “divest from fossil fuels,” phase out oil, gas, and coal production and remake the entire economy around subsidized green mandates.
Your 2020 campaign was shorter than a Garden Gnome but managed to work in these gems:
You told the CNN town hall:
“There’s no question I’m in favor of banning fracking.”
On Jimmy Fallon’s Tonight Show:
“We will end fracking once and for all” while committing to the Green New Deal.
Your $10 trillion climate plan called for no new fossil fuel leases on federal lands, phasing out all oil & gas (even if renewables weren’t ready), a carbon fee, and doubling U.S. payments to the UN Green Climate Fund.
Before that, as California Attorney General (2011-2017), you built a reputation suing our industry.
The lawfare you pursued laid the foundation for the collapse of the California refining industry we are witnessing right now
You even sued the Obama-Biden administration to block new offshore permits off California’s coast.
Remember 2022?
As VP, national gas prices hit $5+/gallon (over $6 in parts of CA).
You told Americans those record prices were “a price to pay for democracy” for Ukraine.
But apparently the freedom of millions of Irainian citizens are not worth $3.97 a gallon now?
That seems - I don't know - selective?
Bottom line.
California still pays the nation’s highest gas prices — thanks to the taxes, mandates, and anti-production policies you championed for years.
Flying cross country (made possible by jet fuel) to North Carolina to make a video isn't going to change that.
And those are the facts - unburdened by what has been.
$GNPX has a catalyst next week "Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting"
Stock is extreme oversold and trading below cash levels (Est. Net Cash/Sh:1.83)
Rep. Tim Moore has been buying this small name over the last months
$GNPX Genprex is a micro-cap biotech with a well-known history of violent upside moves on news and hype. The stock is currently deeply oversold (RSI in the low 20s), trading near multi-year lows.
Adding fuel to the fire:
Congressman Tim Moore has been actively buying shares in recent months, drawing fresh attention from retail traders.
With upcoming catalysts like AACR 2026 data presentations and ongoing lung cancer trials, could the explosive rallies of the past happen again?
Note: There is a catalyst next week at 2026 American Association for Cancer Research (AACR)
@GuntherEagleman@SenSchumer The national average price for regular gasoline peaked at $5.01 per gallon the week of June 13, 2022, during Biden's presidency (EIA data). All-grades average hit $5.11 that same week.
Senator Patty Murray voted yes on key Ukraine aid bills.
In May 2022, she supported the $40.1 billion supplemental appropriations act (Senate 86-11).
In Feb/Apr 2024, she backed the $95.3 billion national security package (Senate 70-29 then final passage), including $60 billion for Ukraine.
Total from these packages: over $100 billion.
I believe Europe has no idea of the scale of destruction Portugal experienced last week and that even now thousands of people remain without internet, running water or power.
What we’re seeing right now is absolutely devastating. I myself was spared by just 50 km, but the weather is still extremely dangerous and tomorrow we’re expecting new alerts for extreme rainfall. I finally get what it’s like to live in hurricane-prone areas.
It seems like Portugal is beginning to face almost identical extreme weather events.
Even though it didn’t hit me head-on, the wind has already caused quite a bit of damage to my house. That’s the downside of living so close to the beach, it’s amazing in summer, but downright frightening in winter.
The destruction is terrifying.
Do you have an idea how much this uranium project could worth now with the uranium near the 100/lb ? $LITM you will soon know when they buy the amount of shares that want 😉 my answer: probably billions JMHO read the press release of Jan 12 😉
$LITM A new parabolic move in junior rare earth names is definitely possible in 2026 📈 🔥
Here’s why juniors could see explosive upside:
- Geopolitical catalysts remain intense: China still dominates ~60-70% of mining and 85-90%+ of processing/magnets.
- Demand tailwinds accelerating: Permanent magnet demand is rising with EVs, renewables, and defense.
- US push for control or acquisition of Greenland
- Momentum is spilling into micro/small-caps as investors rotate from majors like MP Materials
Conditons are ripe for another junior-led parabolic wave in rare earths this year, potentially bigger than late 2025 imho
Small companies like LITM could potentially benefit significantly from heightened rare earths demand and geopolitical tensions, particularly the ongoing US-China supply chain frictions.
Snow Lake Resources is a small-cap exploration-stage company primarily focused on uranium, lithium, and other critical minerals, with a portfolio including projects in North America and Namibia.
In 2025, the company made a strategic C$1.1 million investment in Commerce Resources Corp. to support the Ashram Rare Earths Project in Quebec, Canada one of North America’s largest undeveloped rare earth deposits. This gives LITM indirect exposure to rare earths development amid efforts to build non-Chinese supply chains.
The company has also pursued other critical minerals like gallium (via the Mound Lake project in Ontario, prospective for gallium, lithium, cesium, tantalum, and rare earths), and it emphasizes US-focused and domestic-aligned assets in uranium and related areas, which tie into broader critical minerals priorities.
Demand remains strong for rare earths in EVs, wind turbines, defense and high-tech. This “war” dynamic creates urgency for alternative sources, benefiting junior explorers/developers with North American assets even if early-stage via higher valuations, partnerships, funding, or acquisition interest, as seen in past rare earths cycles.
The company is debt-free, a market of just $60M and $25M in cash
I suggest you to read the recent January presentation. Surprising to spot this ticker getting traction on Reddit this weekend 🤔
As always do your own DD.
Disclosure : I own a long-term position on LITM
What he knows that we dont 🤔
Lets digging it … $GNPX
Rep. Tim Moore, who was ranked as the top-performing member of Congress for stock trades in 2025 has made multiple purchases of Genprex, Inc. shares over the past few months.
Putting real money into a high-risk, micro-cap biotech like Genprex (especially repeatedly and while down significantly) usually signals strong personal conviction rather than a casual punt. No one averages down on a tiny, volatile name like this without believing big upside is coming.
In small-cap biotech, conviction like this often pays off massively on one good catalyst (FDA meeting, more data, partnership).
News that many of investors missed 👇
- The Positive preclinical data for GPX-002 (diabetes gene therapy) dropped in early January 2026 showed normalized glucose in animal models. Company requested FDA meeting for Q1 2026 to advance toward human trials.
- JANE STREET GROUP, LLC added 205,180 shares to their portfolio in Q3 2025, for an estimated $1,737,874
- "This past year was instrumental for Genprex as we expanded our preclinical research beyond Type 1 diabetes and into Type 2 diabetes, marking the achievement of a significant milestone in our diabetes gene therapy program, including the successful initiation of preclinical research in Type 2 diabetic animal models," said Ryan Confer, President and Chief Executive Officer. "Furthermore, we have successfully executed our strategic plan to transfer production of GPX-002 to an experienced Contract Development and Manufacturing Organization (CDMO) and to submit a request to the FDA for a meeting regarding our Investigational New Drug (IND)-enabling studies, marking a pivotal step toward human clinical trials."
2026 Q1 could be huge for this name imho
Disclosure: I own shares of GNPX - Always do your own research.